BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 14529413)

  • 1. Porphyrins as radiosensitizing agents for solid neoplasms.
    Schaffer M; Ertl-Wagner B; Schaffer PM; Kulka U; Hofstetter A; Dühmke E; Jori G
    Curr Pharm Des; 2003; 9(25):2024-35. PubMed ID: 14529413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Application of Photofrin II as a sensitizing agent for ionizing radiation--a new approach in tumor therapy?
    Schaffer M; Ertl-Wagner B; Schaffer PM; Kulka U; Jori G; Dühmke E; Hofstetter A
    Curr Med Chem; 2005; 12(10):1209-15. PubMed ID: 15892632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective targeting and photodynamic destruction of intimal hyperplasia by scavenger-receptor mediated protein-chlorin e6 conjugates.
    Nagae T; Louie AY; Aizawa K; Ishimaru S; Wilson SE
    J Cardiovasc Surg (Torino); 1998 Dec; 39(6):709-15. PubMed ID: 9972886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma.
    Peng Q; Moan J; Ma LW; Nesland JM
    Cancer Res; 1995 Jun; 55(12):2620-6. PubMed ID: 7780978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photosensitizers in photodynamic therapy.
    Levy JG
    Semin Oncol; 1994 Dec; 21(6 Suppl 15):4-10. PubMed ID: 7992105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy for antifibrosis in a rabbit model of filtration surgery.
    Hill RA; Crean DH; Doiron DR; McDonald TJ; Liaw LH; Ghosheh F; Hamilton A; Berns MW
    Ophthalmic Surg Lasers; 1997 Jul; 28(7):574-81. PubMed ID: 9243661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of the possibility of using the photodynamic effect in rheumatology].
    Tauraĭtis VA; Shishporenok SI; Grubina LA; Sarzhevskaia MV; Gurinovich IF; GGurinovich GP; Matulis AA
    Biofizika; 1992; 37(2):345-51. PubMed ID: 7578326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy of squamous cell carcinoma. An evaluation of a new photosensitizing agent, benzoporphyrin derivative and new photoimmunoconjugate.
    Hemming AW; Davis NL; Dubois B; Quenville NF; Finley RJ
    Surg Oncol; 1993; 2(3):187-96. PubMed ID: 8252208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial distribution of liposome encapsulated tin etiopurpurin dichloride (SnET2) in the canine prostate: implications for computer simulation of photodynamic therapy.
    Aniola J; Selman SH; Lilge L; Keck R; Jankun J
    Int J Mol Med; 2003 Mar; 11(3):287-91. PubMed ID: 12579328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photofrin as a specific radiosensitizing agent for tumors: studies in comparison to other porphyrins, in an experimental in vivo model.
    Schaffer M; Schaffer PM; Corti L; Gardiman M; Sotti G; Hofstetter A; Jori G; Dühmke E
    J Photochem Photobiol B; 2002 Apr; 66(3):157-64. PubMed ID: 11960724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced antitumour effect of photodynamic therapy by microtubule inhibitors.
    Ma LW; Berg K; Danielsen HE; Kaalhus O; Iani V; Moan J
    Cancer Lett; 1996 Dec; 109(1-2):129-39. PubMed ID: 9020912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photosensitized processes in vivo: proposed phototherapeutic applications.
    Jori G
    Photochem Photobiol; 1990 Aug; 52(2):439-43. PubMed ID: 2217554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The possible role of ionic species in selective biodistribution of photochemotherapeutic agents toward neoplastic tissue.
    Pottier R; Kennedy JC
    J Photochem Photobiol B; 1990 Dec; 8(1):1-16. PubMed ID: 2127428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Light triggered oxygen-affording engines for repeated hypoxia-resistant photodynamic therapy.
    Zhou TJ; Xing L; Fan YT; Cui PF; Jiang HL
    J Control Release; 2019 Aug; 307():44-54. PubMed ID: 31202726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental (in vivo) study of the capacities of use of radachlorine (chlorine E-6) for photodynamic therapy in ophthalmology].
    Siplivyĭ VI; Bolshunov AV; Reshetnikov AV; Goncharov SE; Armichev AV; Velieva IA; Sosnovskiĭ VV
    Vestn Oftalmol; 2005; 121(5):19-21. PubMed ID: 16274058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy in dermatology with porfimer sodium and benzoporphyrin derivative: an update.
    Lui H
    Semin Oncol; 1994 Dec; 21(6 Suppl 15):11-4. PubMed ID: 7992101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of multiple photosensitizers and wavelengths during photodynamic therapy: a new approach to enhance tumor eradication.
    Nelson JS; Liaw LH; Lahlum RA; Cooper PL; Berns MW
    J Natl Cancer Inst; 1990 May; 82(10):868-73. PubMed ID: 2139704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of benzoporphyrin derivative in malignant and host cell populations of the murine RIF tumor.
    Korbelik M; Krosl G
    Cancer Lett; 1995 Nov; 97(2):249-54. PubMed ID: 7497470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers.
    Lilge L; Wilson BC
    J Clin Laser Med Surg; 1998 Apr; 16(2):81-91. PubMed ID: 9663099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor-mediated targeting of chlorin e6 selectively potentiates its photodynamic activity.
    Gijsens A; Missiaen L; Merlevede W; de Witte P
    Cancer Res; 2000 Apr; 60(8):2197-202. PubMed ID: 10786684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.